Two studies by Liao et al. [26] and Huang et al. [48] for HOXB7 and B9, respectively, reported that significantly more patients had metastatic disease in the high HOX expression group in comparison with the low expression one (Table 1). The gene discussed is HOXB7; the disease is metastatic neoplasm.